Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

44 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Post-first-line FOLFOX chemotherapy for grade 3 neuroendocrine carcinoma.
Hadoux J, Malka D, Planchard D, Scoazec JY, Caramella C, Guigay J, Boige V, Leboulleux S, Burtin P, Berdelou A, Loriot Y, Duvillard P, Chougnet CN, Déandréis D, Schlumberger M, Borget I, Ducreux M, Baudin E. Hadoux J, et al. Among authors: berdelou a. Endocr Relat Cancer. 2015 Jun;22(3):289-98. doi: 10.1530/ERC-15-0075. Epub 2015 Mar 13. Endocr Relat Cancer. 2015. PMID: 25770151
Not All Patients with a Pancreatic Neuroendocrine Tumour Will Benefit from All Approved or Recommended Therapeutic Options: A Real-Life Retrospective Study.
Berdelou A, Boige V, Arfi-Rouche J, Malka D, Ederhy S, Izzedine H, Leboulleux S, Chougnet CN, Burtin P, De Baere T, Laplanche A, Elias D, Schlumberger M, Scoazec JY, Ducreux M, Baudin E. Berdelou A, et al. Neuroendocrinology. 2017;105(1):26-34. doi: 10.1159/000446988. Epub 2016 May 26. Neuroendocrinology. 2017. PMID: 27225439
Post-Radiation Grade 3 Neuroendocrine Carcinoma: A New Entity?
Hadoux J, Blanchard P, Scoazec JY, Burtin P, Planchard D, Malka D, Berdelou A, Boige V, Duvillard P, Leboulleux S, Faron M, Tselikas L, Deutsch E, Ducreux M, Baudin E. Hadoux J, et al. Among authors: berdelou a. Neuroendocrinology. 2021;111(1-2):139-145. doi: 10.1159/000504255. Epub 2019 Oct 22. Neuroendocrinology. 2021. PMID: 31639792
Antiangiogenic Tyrosine Kinase Inhibitors: Occurrence and Risk Factors of Hemoptysis in Refractory Thyroid Cancer.
Lamartina L, Ippolito S, Danis M, Bidault F, Borget I, Berdelou A, Al Ghuzlan A, Hartl D, Blanchard P, Terroir M, Deandreis D, Schlumberger M, Baudin E, Leboulleux S. Lamartina L, et al. Among authors: berdelou a. J Clin Endocrinol Metab. 2016 Jul;101(7):2733-41. doi: 10.1210/jc.2015-4391. Epub 2016 Apr 15. J Clin Endocrinol Metab. 2016. PMID: 27082933
Evaluation of the combination of oxaliplatin and 5-fluorouracil or gemcitabine in patients with sporadic metastatic pulmonary carcinoid tumors.
Walter T, Planchard D, Bouledrak K, Scoazec JY, Souquet PJ, Dussol AS, Guigay J, Hervieu V, Berdelou A, Ducreux M, Arpin D, Lombard-Bohas C, Baudin E. Walter T, et al. Among authors: berdelou a. Lung Cancer. 2016 Jun;96:68-73. doi: 10.1016/j.lungcan.2016.03.018. Epub 2016 Mar 31. Lung Cancer. 2016. PMID: 27133753
Locally unresectable differentiated thyroid cancer: outcomes and perspectives.
Lamartina L, Godbert Y, Nascimento C, Do Cao C, Hescot S, Borget I, Al Ghuzlan A, Hartl D, Hadoux J, Pottier E, Attard M, Berdelou A, Terroir M, Baudin E, Schlumberger M, Leboulleux S; with the support of the TUTHYREF network. Lamartina L, et al. Among authors: berdelou a. Endocrine. 2020 Jul;69(1):133-141. doi: 10.1007/s12020-020-02245-0. Epub 2020 Mar 8. Endocrine. 2020. PMID: 32147774
Postoperative fluorine-18-fluorodeoxyglucose positron emission tomography/computed tomography: an important imaging modality in patients with aggressive histology of differentiated thyroid cancer.
Nascimento C, Borget I, Al Ghuzlan A, Deandreis D, Hartl D, Lumbroso J, Berdelou A, Lepoutre-Lussey C, Mirghani H, Baudin E, Schlumberger M, Leboulleux S. Nascimento C, et al. Among authors: berdelou a. Thyroid. 2015 Apr;25(4):437-44. doi: 10.1089/thy.2014.0320. Epub 2015 Mar 16. Thyroid. 2015. PMID: 25633259
Surgery for Neck Recurrence of Differentiated Thyroid Cancer: Outcomes and Risk Factors.
Lamartina L, Borget I, Mirghani H, Al Ghuzlan A, Berdelou A, Bidault F, Deandreis D, Baudin E, Travagli JP, Schlumberger M, Hartl DM, Leboulleux S. Lamartina L, et al. Among authors: berdelou a. J Clin Endocrinol Metab. 2017 Mar 1;102(3):1020-1031. doi: 10.1210/jc.2016-3284. J Clin Endocrinol Metab. 2017. PMID: 28359102
44 results